BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36801895)

  • 21. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory Effect of Lactobacillus plantarum Extracts on HT-29 Colon Cancer Cell Apoptosis Induced by Staphylococcus aureus and Its Alpha-Toxin.
    Kim H; Kim HS; Park WJ; Chung DK
    J Microbiol Biotechnol; 2015 Nov; 25(11):1849-55. PubMed ID: 26198124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lactobacillus plantarum AS1 binds to cultured human intestinal cell line HT-29 and inhibits cell attachment by enterovirulent bacterium Vibrio parahaemolyticus.
    Satish Kumar R; Kanmani P; Yuvaraj N; Paari KA; Pattukumar V; Arul V
    Lett Appl Microbiol; 2011 Oct; 53(4):481-7. PubMed ID: 21848906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells.
    Chang PY; Peng SF; Lee CY; Lu CC; Tsai SC; Shieh TM; Wu TS; Tu MG; Chen MY; Yang JS
    Int J Oncol; 2013 Oct; 43(4):1141-50. PubMed ID: 23917396
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolite secretions of Lactobacillus plantarum YYC-3 may inhibit colon cancer cell metastasis by suppressing the VEGF-MMP2/9 signaling pathway.
    Yue YC; Yang BY; Lu J; Zhang SW; Liu L; Nassar K; Xu XX; Pang XY; Lv JP
    Microb Cell Fact; 2020 Nov; 19(1):213. PubMed ID: 33228670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular uptake and anticancer effects of mucoadhesive curcumin-containing chitosan nanoparticles.
    Chuah LH; Roberts CJ; Billa N; Abdullah S; Rosli R
    Colloids Surf B Biointerfaces; 2014 Apr; 116():228-36. PubMed ID: 24486834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on anti-colon cancer potential of nanoformulations of curcumin and succinylated curcumin in mannosylated chitosan.
    Idoudi S; Bedhiafi T; Sahir F; Hijji Y; Uddin S; Merhi M; Dermime S; Billa N
    Int J Biol Macromol; 2023 Apr; 235():123827. PubMed ID: 36858085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma.
    Firouzi Amoodizaj F; Baghaeifar S; Taheri E; Farhoudi Sefidan Jadid M; Safi M; Seyyed Sani N; Hajazimian S; Isazadeh A; Shanehbandi D
    J Biochem Mol Toxicol; 2020 Jun; 34(6):e22486. PubMed ID: 32128952
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GABA-producing Lactobacillus plantarum inhibits metastatic properties and induces apoptosis of 5-FU-resistant colorectal cancer cells via GABA
    An J; Seok H; Ha EM
    J Microbiol; 2021 Feb; 59(2):202-216. PubMed ID: 33527319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic and anti-colon cancer properties of curcumin-containing chitosan-pectinate composite nanoparticles.
    Alkhader E; Roberts CJ; Rosli R; Yuen KH; Seow EK; Lee YZ; Billa N
    J Biomater Sci Polym Ed; 2018 Dec; 29(18):2281-2298. PubMed ID: 30376409
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of HT-29 Colon Cancer Cells Apoptosis by Pyrogallol with Growth Inhibiting Efficacy Against Drug-Resistant
    Revathi S; Hakkim FL; Kumar NR; Bakshi HA; Rashan L; Al-Buloshi M; Hasson SSAA; Krishnan M; Javid F; Nagarajan K
    Anticancer Agents Med Chem; 2018; 18(13):1875-1884. PubMed ID: 30081791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined therapy using bevacizumab and turmeric ethanolic extract (with absorbable curcumin) exhibited beneficial efficacy in colon cancer mice.
    Yue GG; Kwok HF; Lee JK; Jiang L; Wong EC; Gao S; Wong HL; Li L; Chan KM; Leung PC; Fung KP; Zuo Z; Lau CB
    Pharmacol Res; 2016 Sep; 111():43-57. PubMed ID: 27241019
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual-label flow cytometry-based host cell adhesion assay to ascertain the prospect of probiotic Lactobacillus plantarum in niche-specific antibacterial therapy.
    Mukherjee S; Ramesh A
    Microbiology (Reading); 2017 Dec; 163(12):1822-1834. PubMed ID: 29091578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Curcumin combined with cis-platinum promote the apoptosis of human colorectal cancer HT29 cells and mechanism.
    Chen GP; Zhang Y; Xu ZY; Yu JF; Wei X
    Int J Clin Exp Pathol; 2017; 10(12):11496-11505. PubMed ID: 31966505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lactobacillus plantarum (VR1) isolated from an ayurvedic medicine (Kutajarista) ameliorates in vitro cellular damage caused by Aeromonas veronii.
    Kumar H; Rangrez AY; Dayananda KM; Atre AN; Patole MS; Shouche YS
    BMC Microbiol; 2011 Jun; 11():152. PubMed ID: 21707995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prophylactic effects of secretion metabolites of dairy lactobacilli through downregulation of ErbB-2 and ErbB-3 genes on colon cancer cells.
    Faghfoori Z; Pourghassem Gargari B; Saber A; Seyyedi M; Fazelian S; Khosroushahi AY
    Eur J Cancer Prev; 2020 May; 29(3):201-209. PubMed ID: 28683007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lactobacillus species inhibitory effect on colorectal cancer progression through modulating the Wnt/β-catenin signaling pathway.
    Ghanavati R; Akbari A; Mohammadi F; Asadollahi P; Javadi A; Talebi M; Rohani M
    Mol Cell Biochem; 2020 Jul; 470(1-2):1-13. PubMed ID: 32419125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.
    Ismail NI; Othman I; Abas F; H Lajis N; Naidu R
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32825505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards effective and stable probiotics.
    Yarullina DR; Damshkaln LG; Bruslik NL; Konovalova OA; Ilinskaya ON; Lozinsky VI
    Int J Risk Saf Med; 2015; 27 Suppl 1():S65-6. PubMed ID: 26639716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free extracts of
    Baghbani-Arani F; Asgary V; Hashemi A
    Nutr Cancer; 2020; 72(8):1390-1399. PubMed ID: 31707847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.